NuPeak Therapeutics, Inc.
PrivateLast Round
Grant
Sep 24, 2020
Total Funding Raised
$3.29M
Company Overview
NuPeak Therapeutics, Inc. is a biotechnology company that develops small-molecule kinase inhibitors to treat respiratory diseases such as asthma, COPD, and post-viral lung inflammation.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuPeak Therapeutics, Inc. Comparables
Compare NuPeak Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aspiro Therapeutics | 81% | |
| Kinaset Therapeutics | 78% | |
| Aer Therapeutics | 75% |
NuPeak Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 24, 2020 | ||||
| Grant | Aug 1, 2018 |
NuPeak Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2020
Secured $3M from the National Heart, Lung, and Blood Institute.
- Aug 1, 2018
$300K grant from the National Heart, Lung, and Blood Institute.
NuPeak Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NuPeak Therapeutics, Inc.'s valuation, stock price, and market status.
Is NuPeak Therapeutics, Inc. a public or private company?
NuPeak Therapeutics, Inc. is a private company.
What is the current stock price of NuPeak Therapeutics, Inc.?
NuPeak Therapeutics, Inc. is a private company with no public stock price. Caplight tracks NuPeak Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is NuPeak Therapeutics, Inc. worth (valuation)?
Valuation information for NuPeak Therapeutics, Inc. is not publicly available.
Can I buy NuPeak Therapeutics, Inc. stock?
NuPeak Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NuPeak Therapeutics, Inc.'s last funding round?
NuPeak Therapeutics, Inc.'s most recent funding round was Grant on September 24, 2020.
Who are the main investors in NuPeak Therapeutics, Inc.?
Key investors in NuPeak Therapeutics, Inc. include National Heart, Lung, and Blood Institute.
Will NuPeak Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for NuPeak Therapeutics, Inc..
How can I track NuPeak Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NuPeak Therapeutics, Inc.'s secondary market activity and sign up for updates.